Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis

J Neurol. 2023 Mar;270(3):1776-1780. doi: 10.1007/s00415-022-11417-z. Epub 2022 Nov 4.
No abstract available

Keywords: Autoantibody; Autoimmune encephalitis; Cerebellar ataxia; Cognitive decline; GTPase Regulator Associated with Focal Adhesion Kinase (GRAF); GTPase-activating protein 2 (ARHGAP2, N-chimerin, chimerin-1); Immunoglobulin G (IgG); Limbic encephalitis; Nadrin; Oligophrenin-like protein 1 (OPHN1L); Polyneuropathy; Rho GTPase-activating protein 10 (ARHGAP10, GRAF2); Rho GTPase-activating protein 17 (ARHGAP17); Rho GTPase-activating protein 26 (ARHGAP26); RhoGAP interacting with CIP4 homologs protein 1 (RICH-1).

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies
  • Autoimmune Diseases of the Nervous System*
  • GTPase-Activating Proteins* / metabolism
  • Humans
  • Immunoglobulin G

Substances

  • rho GTPase-activating protein
  • GTPase-Activating Proteins
  • Autoantibodies
  • Immunoglobulin G
  • ARHGAP26 protein, human
  • ARHGAP17 protein, human